跳至主要内容
临床试验/IRCT2015060712781N4
IRCT2015060712781N4已完成3 期

Evaluation of the effect of intravenous magnesium sulfate in improvement of disability resulted from acute ischemic stroke in patients referred to Ahvaz Golestan hospital

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 75 years(—)
性别
All

入选标准

  • patients with the following conditions were included: 45 to 75 years old patients with ischemic stroke within the middle cerebral artery; patients who had symptoms of focal neurological deficits on arrival; ischemic stroke had occurred within past 24 hours; Modified National Institutes of Health Stroke Scale was between 5 to 25 on arrival; no evidence of a brain hemorrhage in primary CT scan.
  • Exclusion criteria: patients with the following conditions were excluded: prior chronic renal failure or serum Creatinine level above 3 mg/dl; pregnancy; prior heart block or its evidences in initial ECG; prior respiratory failure or oxygen saturation below 90% or respiratory rate below 12 or above 24 per minute; prior neurodegenerative, demyelinating, muscular diseases and brain tumor; acute metabolic disorder (magnesium, sodium and potassium level); life-threatening diseases which may lead to death in the next three months; and patients who need help in daily activities and walking.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

相似试验

Effect of magnesium sulfate in acute ischemic stroke | 临床试验